Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

PubWeight™: 8.51‹?› | Rank: Top 0.1%

🔗 View Article (PMID 9136821)

Published in Gastroenterology on May 01, 1997


G R Locke1, N J Talley, S L Fett, A R Zinsmeister, L J Melton

Author Affiliations

1: Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.

Associated clinical trials:

Study of a Dietary Supplement for Reflux During Sleep (SXDSFRS) | NCT02274636

Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study | NCT02081404

Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study | NCT01574573

Effect of Pantoprazole 40mg Daily vs Placebo on Power Spectral Analysis of the Sleep EEG of Patients With GERD. | NCT00674245

Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule | NCT00579410

A Prospective, Observational Study of the PPI Non-responder | NCT03282084

Efficacy of Zinc L-carnosine in Maintaining Remission of Gastroesophageal Reflux Disease (GERDILOR) | NCT03467438

The Effect of Positional Therapy on Symptoms of Gastroesophageal Reflux Disease: A Prospective Pilot Study | NCT04500288

Articles citing this

(truncated to the top 100)

Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut (2005) 7.35

Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med (2006) 5.24

Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol (2012) 4.47

An evidence-based appraisal of reflux disease management--the Genval Workshop Report. Gut (1999) 3.45

Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol (2000) 2.99

Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut (2013) 2.96

American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology (2011) 2.50

Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies. Am J Gastroenterol (2010) 2.37

Increasing incidence of Barrett's oesophagus in the general population. Gut (2005) 2.34

Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut (2007) 2.28

Reasons for participating in randomised controlled trials: conditional altruism and considerations for self. Trials (2010) 2.25

No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut (2000) 2.16

The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut (2007) 2.10

Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut (2001) 2.05

Long-term therapeutic outcome of patients undergoing ambulatory pH monitoring for chronic unexplained cough. J Clin Gastroenterol (2010) 1.90

Genetic influences in gastro-oesophageal reflux disease: a twin study. Gut (2003) 1.85

Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut (2005) 1.82

Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut (2005) 1.74

Body mass index and Barrett's oesophagus in women. Gut (2009) 1.70

Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study. Gut (2001) 1.66

Approach to managing undiagnosed chest pain: could gastroesophageal reflux disease be the cause? Can Fam Physician (2007) 1.61

Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial. Obesity (Silver Spring) (2013) 1.60

Maximum hyoid displacement in normal swallowing. Dysphagia (2007) 1.56

Esophageal Adenocarcinoma and Its Rare Association with Barrett's Esophagus in Henan, China. PLoS One (2014) 1.53

Psychological factors in gastroesophageal reflux disease measured by scl-90-R questionnaire. Dig Dis Sci (2008) 1.53

Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes. JAMA (2016) 1.52

Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut (2009) 1.49

Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut (1998) 1.48

Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut (2004) 1.47

Gastrointestinal motility disorders and acupuncture. Auton Neurosci (2010) 1.45

The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus (2010) 1.42

Acid perfusion test: a useful test for evaluating esophageal acid sensitivity. Dig Dis Sci (2005) 1.40

Long term failure of endoscopic gastroplication (EndoCinch). Gut (2005) 1.38

Epidemiology of gastroesophageal reflux disease: a general population-based study in Xi'an of Northwest China. World J Gastroenterol (2004) 1.36

The relationship between existence of typical symptoms and psychological factors in patients with erosive esophagitis. J Neurogastroenterol Motil (2012) 1.34

Overlap of Erosive and Non-erosive Reflux Diseases With Functional Gastrointestinal Disorders According to Rome III Criteria. J Neurogastroenterol Motil (2010) 1.33

Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded. J Neurogastroenterol Motil (2011) 1.32

Chronic gastrointestinal symptoms and quality of life in the Korean population. World J Gastroenterol (2008) 1.31

Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study. Clin Gastroenterol Hepatol (2013) 1.29

Endoscopic gastroplication for the treatment of gastro-oesophageal reflux disease: a randomised, sham-controlled trial. Gut (2006) 1.28

Opiate-induced oesophageal dysmotility. Aliment Pharmacol Ther (2009) 1.23

Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease. Surg Endosc (2010) 1.22

Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut (2005) 1.22

Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology (2006) 1.22

Population based study of noncardiac chest pain in southern Chinese: prevalence, psychosocial factors and health care utilization. World J Gastroenterol (2004) 1.22

Symptoms and antireflux medication use following laparoscopic Nissen fundoplication: outcome at 1 and 4 years. JSLS (2003) 1.21

Relationship between Psychological Factors and Quality of Life in Subtypes of Gastroesophageal Reflux Disease. Gut Liver (2009) 1.21

Trends in gastroesophageal reflux disease as measured by the National Ambulatory Medical Care Survey. Dig Dis Sci (2009) 1.21

Prevalence of gastroesophageal reflux disease symptoms and uninvestigated dyspepsia in Korea: a population-based study. Dig Dis Sci (2007) 1.20

NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol (2013) 1.20

Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease. Dig Dis Sci (2007) 1.19

Postmenopausal hormone use and symptoms of gastroesophageal reflux. Arch Intern Med (2008) 1.18

Are rice and spicy diet good for functional gastrointestinal disorders? J Neurogastroenterol Motil (2010) 1.18

Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus. Gastroenterology (2010) 1.18

Symptoms of aerophagia are common in patients on continuous positive airway pressure therapy and are related to the presence of nighttime gastroesophageal reflux. J Clin Sleep Med (2013) 1.17

Prevalence of complicated gastroesophageal reflux disease and Barrett's esophagus among racial groups in a multi-center consortium. Dig Dis Sci (2009) 1.16

Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease. Dig Dis Sci (1999) 1.14

Esophageal squamous cell dysplasia and delayed differentiation with deletion of krüppel-like factor 4 in murine esophagus. Gastroenterology (2010) 1.13

Metabolic syndrome and gastrointestinal diseases. J Gastroenterol (2007) 1.12

The homeodomain protein CDX2 is an early marker of Barrett's oesophagus. J Clin Pathol (2004) 1.12

Barrett's esophagus and the increasing role of endoluminal therapy. Therap Adv Gastroenterol (2008) 1.11

Globus pharyngeus: a review of its etiology, diagnosis and treatment. World J Gastroenterol (2012) 1.10

Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett's esophagus. Am J Physiol Gastrointest Liver Physiol (2008) 1.10

Health-related quality of life in patients with Barrett's esophagus: a systematic review. Clin Gastroenterol Hepatol (2009) 1.09

Asian consensus report on functional dyspepsia. J Neurogastroenterol Motil (2012) 1.09

Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials. Dig Dis Sci (2001) 1.09

Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Gut (2008) 1.09

Gastric cancer and H pylori. Gut (2002) 1.09

Esophageal impedance monitoring for gastroesophageal reflux. J Pediatr Gastroenterol Nutr (2011) 1.08

Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis. Aliment Pharmacol Ther (2015) 1.08

Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Dig Dis Sci (2003) 1.07

Clinical distinct features of noncardiac chest pain in young patients. J Neurogastroenterol Motil (2010) 1.07

Obesity as a risk factor for GERD in Japan. J Gastroenterol (2008) 1.06

Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study. Gut (2005) 1.06

Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all. Dig Dis Sci (2004) 1.04

Studying the overlap between IBS and GERD: a systematic review of the literature. Dig Dis Sci (2006) 1.04

Nonerosive Reflux Disease (NERD) - An Update. J Neurogastroenterol Motil (2010) 1.04

Natural history of dyspepsia. Gut (2002) 1.03

Krüppel-like factor 5 controls keratinocyte migration via the integrin-linked kinase. J Biol Chem (2008) 1.03

Relationships between sleep quality and pH monitoring findings in persons with gastroesophageal reflux disease. J Clin Sleep Med (2007) 1.03

Noncardiac chest pain: epidemiology, natural course and pathogenesis. J Neurogastroenterol Motil (2011) 1.03

Risk factors of gastroesophageal reflux disease in Shiraz, southern Iran. World J Gastroenterol (2007) 1.03

Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms. Ann Surg (2004) 1.02

Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease. World J Gastroenterol (2013) 1.01

Prevalence and risk factors of gastroesophageal reflux disease in Qashqai migrating nomads, southern Iran. World J Gastroenterol (2009) 1.01

Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities? Neurogastroenterol Motil (2011) 1.01

Reflux oesophagitis in adult coeliac disease: beneficial effect of a gluten free diet. Gut (2003) 1.00

Endoscopic full-thickness plication for the treatment of GERD: long-term multicenter results. Surg Endosc (2006) 0.99

A comprehensive review of laparoscopic redo fundoplication. Surg Endosc (2010) 0.99

Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting. Health Qual Life Outcomes (2009) 0.98

Prevalence of hidden gastroparesis in the community: the gastroparesis "iceberg". J Neurogastroenterol Motil (2012) 0.98

Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms. Surg Endosc (2011) 0.98

Quality of life in GERD and Barrett's esophagus is related to gender and manifestation of disease. Am J Gastroenterol (2009) 0.98

Risk factors for gastroesophageal reflux disease, reflux esophagitis and non-erosive reflux disease among Chinese patients undergoing upper gastrointestinal endoscopic examination. World J Gastroenterol (2007) 0.97

Long-term risk of atrial fibrillation with symptomatic gastroesophageal reflux disease and esophagitis. Am J Cardiol (2008) 0.97

The impact of illness in patients with moderate to severe gastro-esophageal reflux disease. BMC Gastroenterol (2005) 0.97

Gastroesophageal reflux disease: Update on inflammation and symptom perception. World J Gastroenterol (2013) 0.97

Association between Helicobacter pylori and Barrett's esophagus: a case-control study. Am J Gastroenterol (2014) 0.96

Risk factors for erosive esophagitis: a cross-sectional study of a large number of Japanese males. J Gastroenterol (2011) 0.96

Functional oesophago-gastric junction imaging. World J Gastroenterol (2006) 0.96

Articles by these authors

The diagnosis of osteoporosis. J Bone Miner Res (1994) 10.90

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43

Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med (1994) 9.25

Hip fractures in the elderly: a world-wide projection. Osteoporos Int (1992) 9.08

Involutional osteoporosis. N Engl J Med (1986) 8.20

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62

Psychotropic drug use and the risk of hip fracture. N Engl J Med (1987) 7.53

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44

The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone (1995) 5.76

A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med (1998) 5.67

Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med (1990) 5.49

Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) (1982) 5.29

A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis (1992) 5.22

Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA (1996) 5.17

A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92

Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84

Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res (1992) 4.75

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 4.74

Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med (1998) 4.66

Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA (1998) 4.62

Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut (1990) 4.60

Simplified assessment of segmental colonic transit. Gastroenterology (1987) 4.59

Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology (1998) 4.52

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology (2007) 4.28

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28

A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res (1998) 4.24

Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology (1993) 4.23

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18

Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16

A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology (1990) 4.02

Potential effect of authorization bias on medical record research. Mayo Clin Proc (1999) 4.01

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut (2008) 3.92

Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90

The prevention and treatment of osteoporosis. N Engl J Med (1992) 3.90

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2001) 3.85

Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut (2008) 3.81

Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology (1990) 3.77

Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med (2001) 3.68

The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology (2001) 3.60

Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest (1981) 3.60

A patient questionnaire to identify bowel disease. Ann Intern Med (1989) 3.43

Thoracic aortic aneurysms: a population-based study. Surgery (1982) 3.36

Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34

A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14

Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology (1989) 3.12

Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08

Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974. Am Rev Respir Dis (1979) 3.06

Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int (2011) 3.04

Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol (1999) 3.01

Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology (1996) 3.00

Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology (1993) 2.99

Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med (1999) 2.98

The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut (2012) 2.96

Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation (1989) 2.94

Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop Relat Res (1981) 2.93

Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92

Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89

Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut (2000) 2.86

Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum (1984) 2.85

Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut (2008) 2.82

Medical costs in community subjects with irritable bowel syndrome. Gastroenterology (1995) 2.81

Epidemiologic features of humeral fractures. Clin Orthop Relat Res (1982) 2.79

Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med (1995) 2.78

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med (2000) 2.77

Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int (2008) 2.74

The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther (2013) 2.73

Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73

The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med (1995) 2.73

Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int (2008) 2.72

Review article: Associations between Helicobacter pylori and obesity--an ecological study. Aliment Pharmacol Ther (2014) 2.69

Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation. Aliment Pharmacol Ther (2014) 2.67

Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci (1991) 2.67

Temporal lobe seizures: lateralization with MR volume measurements of the hippocampal formation. Radiology (1990) 2.56

Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol (1992) 2.54

Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology (1993) 2.52

Long-term survival of a cohort of community residents with asthma. N Engl J Med (1994) 2.47

Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab (2001) 2.43

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol (1998) 2.38

Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res (1999) 2.37

Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther (2013) 2.36

Osteoporosis and the risk of hip fracture. Am J Epidemiol (1986) 2.35

Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35

Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther (2004) 2.35

Sex differences in evaluation and outcome of unstable angina. JAMA (2000) 2.33